Capnocytophaga spp.
Capnocytophaga spp.
MATERIAL SAFETY DATA SHEET – INFECTIOUS SUBSTANCES
SECTION I – INFECTIOUS AGENT
NAME: Capnocytophaga spp.
SYNONYM OR CROSS REFERENCE: C. gingivalis, C. granulosa, C. haemolytica, C. sputigena, C. ochracea, Bacteroides ochraceus (C. canimorsus and C. cynodegmi colonize the oral cavities of dogs and cats, respectively)
CHARACTERISTICS: Gram negative rods, gliding motility, can grow aerobically or anaerobically, medium to long thin rods with tapered ends
SECTION II – HEALTH HAZARD
PATHOGENICITY: Normal flora of oral cavity; involved primarily in periodontal disease; can produce bacteremia, infections of respiratory tract, eye, bone, wounds, soft tissue infections and endocarditis in both immunocompetent and immunocompromised individuals; C. canimorsus and C. cynodegmi can cause localized wound infections and or systemic infections in people who have been bitten, licked or scratched by cats and dogs
EPIDEMIOLOGY: Worldwide; serious infections in immunocompromised; less severe infections in immunocompetent also reported
HOST RANGE: Humans, other mammals
INFECTIOUS DOSE: Unknown
MODE OF TRANSMISSION: Part of normal flora that invade tissue after trauma and in immunocompromised individuals (contamination with secretions from the oral cavity); nosocomial postoperative wound infection
INCUBATION PERIOD: Unknown
COMMUNICABILITY: Not transmitted from person to person
SECTION III – DISSEMINATION
RESERVOIR: Oral cavity
ZOONOSIS: Yes; transmission through bites, licks or scratches from cats and dogs
VECTORS: None
SECTION IV – VIABILITY
DRUG SUSCEPTIBILITY: Susceptible to penicillins and cephalosporins, carbapenems, fluoroquinolones, chloramphenicol, clindamycin and erythromycin
DRUG RESISTANCE: Resistant to aminoglycosides, trimethoprim, metronidazole and aztreonam; ß-lactamase production has been reported
SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to 1% sodium hypochlorite, 70% ethanol, 2% glutaraldehyde, formaldehyde
PHYSICAL INACTIVATION: Inactivated by moist heat (121°C for 15 min) and dry heat 160-170°C for at least 1 hour
SURVIVAL OUTSIDE HOST: Does not survive under aerobic conditions – requires presence of carbon dioxide or anaerobic conditions
SECTION V – MEDICAL
SURVEILLANCE: Monitor for symptoms and confirm bacteriologically
FIRST AID/TREATMENT: Surgical drainage, antibiotic therapy
IMMUNIZATION: None
PROPHYLAXIS: Antibiotic prophylaxis consisting of amoxicillin/clavulanic acid for all immunocompromised patients who have been bitten by a dog or cat
SECTION VI – LABORATORY HAZARDS
LABORATORY-ACQUIRED INFECTIONS: None reported to date
SOURCES/SPECIMENS: Sputum, throat specimens, blood, bronchial specimens, spinal fluid
PRIMARY HAZARDS: Accidental parenteral inoculation, direct contact of mucous membranes (or wounds, cuts on skin)
SPECIAL HAZARDS: None
SECTION VII – RECOMMENDED PRECAUTIONS
CONTAINMENT REQUIREMENTS: Well designed laboratory with good microbiological practices; this level of containment does not allow for any additional risk presenting for those persons with compromised immunity
PROTECTIVE CLOTHING: Laboratory coat; gloves when direct contact with infectious materials is unavoidable
OTHER PRECAUTIONS: None
SECTION VIII – HANDLING INFORMATION
SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with paper towel and apply 1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up
DISPOSAL: Decontaminate before disposal; steam sterilization, chemical disinfection, incineration
STORAGE: In sealed containers that are appropriately labelled
SECTION IX – MISCELLANEOUS INFORMATION
Date prepared: January 2000
Prepared by: Office of Laboratory Security, PHAC
Although the information, opinions and recommendations contained in this Material Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date.
Copyright © Health Canada, 2001
This MSDS / PSDS document, provided by Public Health Agency of Canada (PHAC), is offered here as a FREE public service to visitors of www.EHS.com. As outlined in this site’s Terms of Use, VelocityEHS is not responsible for the accuracy, content or any aspect of the information contained therein.
Need an SDS? Search our entire SDS database containing millions of documents.